Cargando…
Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer
Gastric cancer (GC) is one of the leading causes of cancer-related deaths, with limited improvement in its clinical outcome worldwide. Aberrant mucin-type O-glycosylation is a critical event widespread in the development of GC. Polypeptide N-acetylgalactosaminyltransferases (GALNTs) regulate the ini...
Autores principales: | Guo, Yan, Shi, Jingjing, Zhang, Jun, Li, Haixin, Liu, Ben, Guo, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511018/ https://www.ncbi.nlm.nih.gov/pubmed/28744137 http://dx.doi.org/10.2147/OTT.S138590 |
Ejemplares similares
-
Polypeptide N-acetylgalactosaminyltransferase-Associated Phenotypes in Mammals
por: Kato, Kentaro, et al.
Publicado: (2021) -
Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular
metastasis-associated behavior in gastric cancer
por: HUA, DONG, et al.
Publicado: (2012) -
Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival
por: Li, Z, et al.
Publicado: (2011) -
N-acetylgalactosaminyltransferases in cancer
por: Hussain, Muhammad Ramzan Manwar, et al.
Publicado: (2016) -
Polypeptide N-acetylgalactosaminyltransferase-6 expression independently predicts poor overall survival in patients with lung adenocarcinoma after curative resection
por: Li, Zhi, et al.
Publicado: (2016)